Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing
A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II
Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84